Patients' and physicians' perceptions of the travoprost dosing aid: An open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension

Clinical Therapeutics

Volumn 28, Issue 11, 2006, Pages 1803-1811

  Flowers, Brian ^a   Wand, Martin ^b   Piltz Seymour, Jody ^c   Berke, Stanley J ^d   Day, Douglas ^e   Teague, James ^f   Smoot, Tonya M ^f   Landry, Theresa A ^f   Bergamini, Michael V W ^f   Mallick, Sushanta ^f  

^a Ophthalmology Associates   (United States)

^b Consulting Ophthalmologists ^*  (United States)

^c Keystone Eye Associates Subspecialty Center   (United States)

^d OPHTHALMIC CONSULTANTS OF LONG ISLAND   (United States)

^e Omni Eye Services   (United States)

^f ALCON RESEARCH LTD   (United States)

Author keywords

adherence; compliance; glaucoma; travoprost

Indexed keywords

PROSTAGLANDIN DERIVATIVE; TRAVOPROST;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL; CONSUMER ATTITUDE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; EYE PAIN; FEMALE; HEALTH SURVEY; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN; RECTUM HEMORRHAGE; THROAT IRRITATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; CLOPROSTENOL; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PHYSICIANS; PROSTAGLANDINS, SYNTHETIC;

EID: 33845963145     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2006.11.001     Document Type: Article

References (15)

1. Quigley H.A., and Broman A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 90 (2006) 262-267
2. Schwartz G.F. Compliance and persistency in glaucoma follow-up treatment. Curr Opin Ophthalmol 16 (2005) 114-121
3. Tsai J.C., McClure C.A., Ramos S.E., et al. Compliance barriers in glaucoma: A systematic classification. J Glaucoma 12 (2003) 393-398
4. Sleath B., Robin A.L., Covert D., et al. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology 113 (2006) 431-436
5. Winfield A.J., Jessiman D., Williams A., and Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol. 74 (1990) 477-480
6. Garber M.C., Nau D.P., Erickson S.R., et al. The concordance of self-report with other measures of medication adherence: A summary of the literature. Med Care. 42 (2004) 649-652
7. discussion 1073. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 21 (1999) 1074-1090
8. Las Vegas, Nev. Robin A.L., Novack G.D., Covert D., et al. Adherence in glaucoma: Objective measurement of patients' use of medication. Presented at: Annual Meeting of the American Academy of Ophthalmology (November 11-14, 2006)
9. Weinreb R.N., and Khaw P.T. Primary open-angle glaucoma. Lancet 363 (2004) 1711-1720
10. Taylor S.A., Galbraith S.M., and Mills R.P. Causes of non-compliance with drug regimens in glaucoma patients: A qualitative study. J Ocul Pharmacol Ther. 18 (2002) 401-409
11. Gurwitz J.H., Glynn R.J., Monane M., et al. Treatment for glaucoma: Adherence by the elderly. Am J Public Health. 83 (1993) 711-716
12. Boden C., Sit A., and Weinreb R.N. Accuracy of an electronic monitoring and reminder device for use with travoprost eye drops. J Glaucoma. 15 (2006) 30-34
13. Lauritsen K., Degl' Innocenti A., Hendel L., et al. Symptom recording in a randomised clinical trial: Paper diaries vs. electronic or telephone data capture. Control Clin Trials 25 (2004) 585-597
14. Friedman DS, Jampel HD, Congdon NG, et al. The Travatan Dosing Aid accurately records when drops are taken. Am J Ophthalmol. In press.
15. Kass M.A., Gordon M., and Meltzer D.W. Can ophthalmologists correctly identify patients defaulting from pilo carpine therapy?. Am J Ophthalmol. 101 (1986) 524-530